StockData
Trulieve Cannabis Corp. logo

Trulieve Cannabis Corp. (TRLV) stock

TRLVNYSEMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 5/3033% below fair value
$10.02−0.05 (-0.50%)

Close on Nov 18, 2026Market cap $1.93BP/E –Yield –

Trulieve Cannabis revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Trulieve Cannabis's revenue for the twelve months ending Jun 30, 2026 was $1.14B, down 3.9% year over year. For fiscal 2025 it was $1.18B, down 0.4% from the year before. The highest annual figure on record is $1.22B in fiscal 2022.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$1.18B-0.4%
FY2024Dec 31, 2024$1.19B+5.1%
FY2023Dec 31, 2023$1.13B-7.3%
FY2022Dec 31, 2022$1.22B+30.7%
FY2021Dec 31, 2021$931.93M+78.7%
FY2020Dec 31, 2020$521.53M+106.3%
FY2019Dec 31, 2019$252.82M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$270.95M-10.3%
Q1 FY2026Mar 31, 2026$286.75M-3.7%
Q4 FY2025Dec 31, 2025$293.15M-2.7%
Q3 FY2025Sep 30, 2025$288.19M+1.4%
Q2 FY2025Jun 30, 2025$302.09M-0.4%
Q1 FY2025Mar 31, 2025$297.76M+0.0%
Q4 FY2024Dec 31, 2024$301.15M+4.9%
Q3 FY2024Sep 30, 2024$284.28M+3.3%
Q2 FY2024Jun 30, 2024$303.44M+7.7%
Q1 FY2024Mar 31, 2024$297.62M+4.3%
Q4 FY2023Dec 31, 2023$286.97M-3.9%
Q3 FY2023Sep 30, 2023$275.21M-6.8%
Q2 FY2023Jun 30, 2023$281.80M-10.2%
Q1 FY2023Mar 31, 2023$285.21M-10.2%
Q4 FY2022Dec 31, 2022$298.48M-0.1%
Q3 FY2022Sep 30, 2022$295.35M+31.8%
Q2 FY2022Jun 30, 2022$313.84M+45.9%
Q1 FY2022Mar 31, 2022$317.75M+63.9%
Q4 FY2021Dec 31, 2021$298.90M+77.5%
Q3 FY2021Sep 30, 2021$224.09M+64.4%
Q2 FY2021Jun 30, 2021$215.12M+78.1%
Q1 FY2021Mar 31, 2021$193.82M+101.8%
Q4 FY2020Dec 31, 2020$168.44M–
Q3 FY2020Sep 30, 2020$136.27M–
Q2 FY2020Jun 30, 2020$120.77M–
Q1 FY2020Mar 31, 2020$96.06M–

More Trulieve Cannabis figures

See a number that looks wrong?